Critique: Opinion | For Some Patients, Cancer Is Becoming Like a Chronic Illnes…

Source: nytimes
Authors: (none listed)
URL: https://www.nytimes.com/2026/05/10/opinion/terminal-cancer-chronic-illness-health.html

What the article reports

Dr. Daniela Lamas, a critical care physician writing as a guest essayist, argues that advances in immunotherapy and targeted cancer drugs have created a growing population of patients living with advanced cancer as a chronic condition rather than a terminal sentence. Through the experiences of several patients and interviews with two specialist physicians, she contends that oncology's current cultural frameworks — bell-ringing ceremonies, battle metaphors, "survivor" language — are inadequate for this new reality, and calls for integrated palliative and mental-health support alongside continued treatment.

Factual accuracy — Sound

The verifiable medical claims are consistent with established oncology literature and are appropriately hedged. The description of immunotherapy as having "transformed outcomes in people with even very advanced kidney cancer" is well-supported by published data on checkpoint inhibitors (nivolumab/ipilimumab combinations). The H.I.V. parallel — that early antiretroviral therapy created a population of people living with the virus rather than dying from it — is accurate and widely cited in chronic-illness literature. Dr. Leah Rosenberg is correctly identified as practicing palliative care at Massachusetts General Hospital; Dr. Ann LaCasce is correctly identified as a lymphoma specialist at Dana-Farber; Dr. Rohan Garje is identified at Baptist Health South Florida, all checkable affiliations. No numerical claims are introduced that could be falsified without sourcing — the piece wisely avoids citing specific survival statistics it does not document. The primary factual weakness is that claims such as "15 years ago, many patients with metastatic cancer expected to live a few months" are attributed paraphrastically to Dr. Rosenberg but presented without any epidemiological anchoring.

Framing — Favorable

1. "The absence of that script is itself a kind of harm" — The author states this as an unattributed declarative rather than a clinical or expert claim. As an opinion piece this is within bounds, but the assertion rests on no cited evidence about patient outcomes; it is the author's moral framing presented as fact.

2. "These are patients that oncology was not built to care for" — A sweeping institutional indictment offered in the author's own voice. It may well be accurate, but the piece does not quote any oncologist pushing back on this framing, which would strengthen rather than undermine the argument.

3. The opening bell-ringing anecdote is deployed to frame the entire piece around what oncology gets wrong before any affirmative description of the field. The sequencing — failure first, reform second — is an editorial choice that colors the reader's prior.

4. "Dr. Garje and his colleagues tell their patients to ring the bell whenever they want" — This closing anecdote is used to illustrate physician adaptability, arriving as a redemptive note. It is effective narrative craft, but it answers the essay's critique with a single practitioner's workaround rather than systemic evidence of change.

Note: This is a clearly labeled Guest Essay / Opinion piece. Neutrality is not the standard here. The above items are offered as framing observations, not as defects.

Source balance

Ratio: All six voices — patients and clinicians alike — are aligned with the essay's thesis. No oncologist, ethicist, or health-system administrator is quoted offering a competing view (e.g., that existing survivorship programs adequately address the gap, or that the bell-ringing critique oversimplifies). For an opinion essay this is acceptable, but it limits the argumentative texture.

Omissions

1. Epidemiological scale — The piece does not quantify how many patients currently live in this "gray zone." Without even a rough figure (e.g., the number of Americans living with Stage 4 cancer on active treatment), the reader cannot gauge whether the problem is rare or common.

2. Existing survivorship infrastructure — Major cancer centers have survivorship clinics and psycho-oncology programs. The piece acknowledges palliative care but does not assess how widely such programs exist or why they are not reaching patients like Boren — an omission that makes the gap feel more absolute than it may be.

3. Counterpoint from within oncology — No voice argues that the field has already begun meaningfully adapting, or that the bell-ringing framing is a local-institution phenomenon rather than a universal standard. This would sharpen rather than undercut the essay.

4. Insurance and access context — Lifelong immunotherapy is extraordinarily expensive. The financial burden on patients living in the "gray zone" goes unmentioned, despite being central to whether patients can actually sustain the kind of life the essay describes.

5. The opinion_unmarked flag is flagged not because the label is absent (it is clearly marked "Guest Essay") but because several declarative sentences ("The absence of that script is itself a kind of harm") read as news-register factual claims and a less attentive reader might not register the opinion framing.

What it does well

• Transparency of authorial standpoint: The byline immediately discloses Dr. Lamas's clinical role — "a pulmonary and critical care physician at Brigham and Women's Hospital" — so readers can calibrate her perspective from the first line.
• Concrete, humanizing case study: "He could barely breathe" and "selected the music for his funeral" ground the abstract policy argument in specific, verifiable patient experience rather than generalized claims.
• Productive analogy: The H.I.V./antiretroviral parallel — "In some ways, it was easier to work with people who were dying than those who were living with H.I.V., but not yet sick" — is historically apt and illuminates the clinical and psychological novelty of the chronic-cancer situation.
• Internal sourcing discipline: The three physician voices are identified by name, institution, and subspecialty, meeting a basic verification standard often absent in narrative medicine writing.
• Constructive close: Rather than ending on institutional failure, the essay concludes with Dr. Garje's adaptive practice — "Let's do it today" — offering the reader a model rather than only a critique.

Rating

Overall: 8/10 — A well-crafted, transparently labeled opinion essay whose main limitation is that all sources reinforce a single thesis and key contextual data (scale, cost, existing programs) are absent.